Endotoxin contamination contributes to the in vitro cytokine-inducing activity of osteopontin preparations

Journal of Interferon and Cytokine Research

Volumn 25, Issue 5, 2005, Pages 277-282

  Konno, Satoshi ^a   Hoshi, Takuya ^b   Taira, Toshio ^b   Plunkett, Beverly ^a   Huang, Shau Ku ^a  

^a JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

^b Hokudo Co Ltd   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGAROSE; CYTOKINE; ENDOTOXIN; INTERLEUKIN 12P40; INTERLEUKIN 6; INTERLEUKIN 8; OSTEOPONTIN; POLYMYXIN B; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL FUNCTION; CELL ISOLATION; CULTURE MEDIUM; CYTOKINE PRODUCTION; DRUG MECHANISM; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PURIFICATION; TH2 CELL;

ANIMALS; CYTOKINES; DRUG CONTAMINATION; ENDOTOXINS; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-12; INTERLEUKIN-12 SUBUNIT P40; INTERLEUKIN-6; INTERLEUKIN-8; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; MICE; OSTEOPONTIN; PROTEIN SUBUNITS; RECOMBINANT PROTEINS; SIALOGLYCOPROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 18644385891     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2005.25.277     Document Type: Article

References (23)

1. DENHARDT, D.T., NODA, M., O'REGAN, A.W., PAVLIN, D., and BERMAN, J.S. (2001). Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J. Clin. Invest. 107, 1055-1061.
2. RITTLING, S.R., and CHAMBERS, A.F. (2004). Role of osteopontin in tumour progression. Br. J. Cancer 90, 1877-1881.
3. ASHKAR, S., WEBER, G.F., PANOUTSAKOPOULOU, V., SANCHIRO, M.E., JANSSON, M., ZAWAIDEH, S., RITTLING, S. R., DENHARDT, D.T., GLIMCHER, M.J., and CANTOR, H. (2000). Eta-1 (osteopontin): an early component of type 1 (cell-mediated) immunity. Science 287, 860-864.
4. CHABAS, D., BARANZINI, S.E., MITCHELL, D., BERNARD, C.C.A., RITTLING, S.R., DENHARDT, D.T., RAYMOND, A.S., LOCK, C., KARPUJ, M., PEDOTTI, R., HELLER, R., OKSENBERG, J.R., and STEINMAN, L. (2001). The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science 294, 1731-1735.
5. JANSSON, M., PANOUTSAKOPOULOU, V., BAKER, J., KLEIN, L., and CANTOR, H. (2002). Attenuated experimental autoimmune encephalomyelitis in Eta-1/osteopontin-deficient mice. J. Immunol. 168, 2096-2099.
6. YUMOTO, K., ISHIJIMA, M., RITTLING, S.R., TSUUJI, K., TSUCHIYA, Y., KON, S., NIFUJI, A., UEDE, T., DENHARDT, D.T., and NODA, M. (2000). Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice. Proc. Natl. Acad. Sci. USA 99, 4556-4561.
7. NAU, G. J., LIAW, L., CHUPP, G.L., BERMAN, J.S., HOGAN, B.L.M., and YOUNG, R.A. (1999). Attenuated host resistance against Mycobacterium bovis BCG infection in mice lacking osteopontin. Infect. Immun. 67, 4223-4230.
8. OHSIMA, S., YAMAGUCHI, N., NISHIOKA, K., MIMA, T., ISHII, T., UMESHITA-SASAI, M., KOBAYASHI, H., SHIMIZU, M., KATADA, Y., WAITANI, S., MURATA, N., NOMURA, S., MATAUNO, H., MATAYAMA, R., KON, S., INOBE, M., UEDE, T., KAWASE, I., and SAEKI, Y. (2002). Enhanced local production of osteopontin in rheumatoid joints. J. Rheumatol. 29, 2061-2067.
9. KOGUCHI, Y., KAWAKAMI, K., UEZU, K., FUKUSHIMA, K., KON, S., MAEDA, M., NAKAMOTO, A., OWAN, I., KUBA, M., KUDEKEN, N., AZUMA, M., YARA, S., SHINZATO, T., HIGA, F., TATEYAMA, M., KADOTA, J., MUKAE, H., KOHNO, S., UEDE, T., and SAITO, A. (2003). High plasma osteopontin level and its relationship with interleukin-12-mediated type 1 T helper cell response in tuberculosis. Am. J. Respir. Crit. Care Med. 167, 1355-1359.
10. VOGT, M.H., LOPATINSKAYA, L., SMITS, M., POLMAN, C.H., and NAGELKERKEN, L. (2003). Elevated osteopontin levels in active relapsing-remitting multiple sclerosis. Ann. Neurol. 53, 819-822.
11. KOGUCHI, Y., KAWAKAM, K., KON, S., SEGAWA, T., MAEDA, M., UEDE, T., and SAITO, A. (2001). Penicillium marneffei causes osteopontin-mediated production of interleukin-12 by peripheral blood mononuclear cells. Infect. Immun. 70, 1042-1048.
12. LEALI, D., DELL'ERA, P., STABILE, H., SENNINO, B., CHAMBERS, A.F., NALDINI, A., SOZZANI, S., NICO, B., RIBATTI, D., and PRESTA, M. (2003). Osteopontin (Eta-1) and fibroblast growth factor-2 cross-talk in angiogenesis. J. Immunol. 171, 1085-1093.
13. WEBER, G.F., ZAWAIDEH, S., HIKITA, S., KUMAR, V.A., CANTOR, H., and ASHLAR, S. (2002). Phosphorylation-dependent interaction of osteopontin with its receptors regulates macrophage migration and activation. J. Leukocyte Biol. 72, 752-756.
14. GAO, B., and TSAN, M.F. (2003). Endotoxin contamination in recombinant human heat shock protein 70 (Hsp70) preparation is responsible for the induction of tumor necrosis factor alpha release by murine macrophages. J. Biol. Chem. 278, 174-179.
15. GAO, B., and TSAN, M.F. (2003). Recombinant human heat shock protein 60 does not induce the release of tumor necrosis factor alpha from murine macrophages. J. Biol. Chem. 278, 22523-22529.
16. SURI, R.M., and AUSTYN, J.M. (1998). Bacterial lipopolysaccharide contamination of commercial collagen preparations may mediate dendritic cell maturation in culture. J. Immunol. Methods 214, 149-163.
17. BAUSINGER, H., LIPSKER, D., ZIYLAN, U., MANIE, S., BRIAND, J.P., CAZENAVE, J.P., MULLER, S., HAEUW, J.F., RAVANAT, C., DE LA SALLE, H., and HANAU, D. (2002). Endotoxin-free heat-shock protein 70 fails to induce APC activation. Eur. J. Immunol. 32, 3708-3713.
18. O'REGAN, A. W., CHUPP, G.L., LOWRY, J.A., GOETSCHKES, M., MULLIGAN, N., and BERMAN, J.S. (1999). Osteopontin is associated with T cells in sarcoid granulomas and has T cell adhesion and cytokine-like properties. J. Immunol. 162, 1024-1031.
19. CHIOCCHETTI, A., INDELICATO, M., BENSI, T., MESTURINI, R., GIORDANO, M., SAMETTI, S., CASTELLI, L., BOTTAREL, F., CLORINADA, M., GARBARINI, L., GIACOPELLI, F., VALESINI, G., SANTORO, C., DIANZANI, I., RAMENGHI, U., and DIANZANI, U. (2004). High levels of osteopontin associated with polymorphisms in its gene are a risk factor for development of autoimmunity/lymphoproliferation. Blood 103, 1376-1382.
20. WEISS, J.M., RENKL, A.C., MAIER, C.S., KIMMIG, M., LIAW, L., AHRENS, T., KON, S., MAEDA, M., HOTTA, H., UEDE, T., and SIMON, J.C. (2001). Osteopontin is involved in the initiation of cutaneous contact hypersensitivity by inducing Langerhans and dendritic cell migration to lymph nodes. J. Exp. Med. 194, 1219-1229.
21. O'REGAN, A.W., HAYDEN, J.M., and BERMAN, J.S. (2000). Osteopontin augments CD3-mediated interferon-gamma and CD40 ligand expression by T cells, which results in IL-12 production from peripheral blood mononuclear cells. J. Leukocyte Biol. 68, 495-502.
22. HELLUIN, O., CHAN, C., VILAIRE, G., MOUSA, S., DEGRADO, W.F., and BENNETT, J.S. (2000). The activation state of alphavbeta 3 regulates platelet and lymphocyte adhesion to intact and thrombin-cleaved osteopontin. J. Biol. Chem. 275, 18337-18343.
23. KON, S., MAEDE, M., SEGAWA, T., HAGIWARA, Y., HORIKOSHI, Y., CHIKUMA, S., TANAKA, K., RASHID, M.M., INOBE, M., CHAMBERS, A.F., and UEDE, T. (2000). Antibodies to different peptides in osteopontin reveal complexities in the various secreted forms. J. Cell. Biochem. 77, 487-498.